Allogene Therapeutics, Inc. (ALLO) — SC 13G/A Filings
All SC 13G/A filings from Allogene Therapeutics, Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Oct 22, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
-
FMR LLC & Abigail Johnson Hold 14.999% Stake in Allogene Therapeutics
— Feb 9, 2024 Risk: low
FMR LLC, a major investment firm, and its principal owner, Abigail P. Johnson, have updated their ownership stake in Allogene Therapeutics Inc. (ALLO) to 14.999 -
BlackRock Amends Allogene Therapeutics Stake, Remains Passive Investor
— Jan 29, 2024
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, disclosing its ownership in Allogene Therapeutics, Inc. as of December 31, 2023. This filing indic -
State Street Exits Allogene Therapeutics Stake
— Jan 23, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 23, 2024, indicating its ownership of Allogene Therapeutics, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX